Does folic acid reduce cardiovascular deterioration in hemodialysis patients?
This article has no abstract so we have provided the first paragraph of the full text.
Elevated serum total homocysteine (tHcy) level, a risk factor for cardiovascular disease, is prevalent in patients with chronic renal failure. Studies have shown that folic acid reduces tHcy concentrations in people with kidney disease, and Vianna et al. have now investigated whether this folate-induced lowering of tHcy reduces the risk of cardiovascular deterioration.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
